Close
Digital Health & Ai Innovation summit 2026
APE 2026

Sectra and SyntheticMR extend cooperation to distribute SyntheticMR’s software

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from...

The federal government has formally withdrawn the Biden-era minimum...
IT and Medical company Sectra and SyntheticMR AB, have signed a distribution agreement for SyntheticMR AB’s software-based technology for significantly improved patient flow and analysis of MR examinations.

IT and Medical company Sectra and SyntheticMR AB, have signed a distribution agreement for SyntheticMR AB’s software-based technology for significantly improved patient flow and analysis of MR examinations.

According to the agreement, Sectra will distribute SyntheticMR’s software, SyMRI Suite, as a plug-in in its PACS system (Picture Archiving Communication System).

Torbjörn Kronander, President of Sectra’s medical business said, With SyntheticMR’s software as part of our PACS system, we will significantly increase not only the efficiency of the actual MR examinations, but also the effectiveness of the radiologists, through enhanced possibilities for identifying pathological tissue.

Marcel Warntjes, President of SyntheticMR says, As a result of the distribution agreement, we are deepening the cooperation that we initiated with Sectra nearly a year ago.  For SyntheticMR, the agreement is an important step in our commercialization process.

Latest stories

Related stories

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Purehealth, Dorchester Partner to Bring Luxury Hospitality in Healthcare

PureHealth has gone on to announce a first-of-its-kind partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »